Clinical trial
A Trial of CS-747 (Prasugrel) Compared With Clopidogrel in Patients Undergoing…
NCT00059215 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00059215 |
|---|---|
| Title | A Trial of CS-747 (Prasugrel) Compared With Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention (PCI) |
| Official title | A Double-Blind, Randomized, Multicenter, Dose-Ranging Trial of CS-747 Compared With Clopidogrel in Subjects Undergoing Percutaneous Coronary Intervention |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cardiovascular Diseases, Heart Diseases |
| Intervention type | Drug |
| Interventions | Prasugrel (CS-747), Clopidogrel |
| Enrollment | 905 |
| Start date | Apr 1, 2003 |
| Primary completion | Jan 1, 2004 |
| Completion | Jan 1, 2004 |
| First posted | Apr 23, 2003 |
| Last update posted | May 25, 2010 |
| Countries | Canada, United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: